Today: 27 June 2026
Zoom Communications Stock Is Back Near Highs. Earnings Will Test the AI Push

Zoom Communications Stock Is Back Near Highs. Earnings Will Test the AI Push

SAN JOSE, California, May 9, 2026, 11:02 PDT

Zoom Communications Inc. wrapped up Friday trading just shy of the session high, with shares settling at $109.21—an uptick from Thursday’s $108.36 close. The collaboration-software stock reached $109.41 at its intraday peak, company market data indicated. That move adds a bit of steam ahead of the company’s next earnings report, now less than two weeks away.

Timing is key here. Zoom will release its fiscal first-quarter 2027 numbers after the bell on May 21, and plans to hold an investor webinar at 5 p.m. EDT. That puts the spotlight right back on revenue growth, margins, and how the company is handling its artificial intelligence push.

The report lands on the heels of a shakeup in leadership. Aparna Bawa, Chief Operating Officer, stepped down effective May 8, after letting Zoom know in March she intended to exit. In the filing, Zoom clarified Bawa’s departure wasn’t the result of a dispute with the company.

Zoom shares climbed, riding a tech-friendly week that saw both the S&P 500 and Nasdaq Composite notch fresh records Friday, buoyed by a jobs report that topped estimates. While the broader appetite for tech lifted the sector, Zoom’s narrative is more specific: the company is betting that new AI tools can inject fresh momentum into its established video-meeting business and drive more predictable enterprise growth.

The company has stuck to that angle. On May 4, Zoom rolled out its Solopreneur 50 initiative and shared survey data showing how small business owners are turning to AI to take over jobs that once required staff. “AI is decoupling growth from hiring,” said Kimberly Storin, Zoom’s chief marketing officer—a line that spells out exactly what Zoom wants investors to notice. GlobeNewswire

Zoom turned in fiscal 2026 revenue of $4.87 billion, a 4.4% increase, with enterprise revenue climbing 6.5% to $2.93 billion. Cash and marketable securities finished at $7.8 billion. CEO Eric Yuan pointed to a strategy of “durable, profitable growth.” Zoom Communications, Inc.

Wall Street isn’t exactly giving Zoom an easy ride. Out of 28 analysts tracked by MarketScreener, the average price target sits at $97.33—noticeably below Zoom’s most recent close of $109.21. Still, the consensus rating holds steady at “outperform.” MarketScreener

Here’s the core worry: Zoom faces heavyweight rivals able to roll communications features into broad, bundled deals. The company’s annual filing points to Microsoft 365 with Teams, Google Workspace with Meet, and Cisco Webex as key competitors. Zoom also flagged the threat could ramp up as AI and fresh products hit the market.

So May 21 isn’t just another quarterly report—it’s a test of the stock’s recent rally. The key: investors looking for hard proof that AI Companion, contact-center offerings, and bigger enterprise deals are actually driving paid growth, enough to balance out softness in the main meetings segment.

For the moment, Zoom is back in focus. The stock needs to prove this bounce isn’t just riding a stronger tech tape.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Honeywell prepares for stock split, Aerospace shares debut at $464
    June 27, 2026, 11:58 AM EDT. Honeywell (NASDAQ:HON) ended Friday at $232.21 ahead of a major corporate split set for Monday. Two old Honeywell shares will convert into one Honeywell Technologies share and one Honeywell Aerospace (NASDAQ:HONA) share. The combined value at Friday's close stood at $464.42. Honeywell Aerospace will join the S&P 500 and S&P 100 indexes, replacing Honeywell International in the latter. Honeywell Technologies maintains its S&P 500 and Dow Jones Industrial Average listings. The split includes a 1-for-2 reverse stock split reducing parent shares from 634 million to about 317 million. The upcoming split week is closely watched as investors compare combined share values post-distribution.

Latest articles

PayPal stock surge shifts short-interest story into next week

PayPal stock surge shifts short-interest story into next week

27 June 2026
PayPal surged 4.5% to $44.29 Friday on trading volume more than double its 65-day average, following a 9.7% jump in short interest to 54.35 million shares as of June 15, equal to 6.2% of float; despite the rally, shares remain 44% below last year’s high, with the stock still seen as a turnaround play and a shortened trading week ahead due to the July 3 U.S. holiday.
Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

27 June 2026
Uber surged 5.47% to $76.20 on Friday with trading volume 3.46 times its 65-day average, as investors weighed tighter U.S. driver background checks set to remove tens of thousands of gig workers starting Monday—raising potential impacts on trips, wait times, and margins while the stock remains 25.3% below its 52-week high.
Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

27 June 2026
Honeywell’s two-for-one split launches Monday, giving investors one Honeywell Technologies share and one Honeywell Aerospace (HONA) share for every two old shares, with the combined package valued at $464.42 at Friday’s close; both stocks debut as separate S&P 500 members, while HONA joins the S&P 100, setting up a pivotal test for holders as the market reopens.
Generate Biomedicines stock ends week back above IPO price as volume jumps

Generate Biomedicines stock ends week back above IPO price as volume jumps

27 June 2026
Generate Biomedicines (NASDAQ:GENB) surged 13.7% since June 18 to close Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as investors weigh its $516.6M cash pile, ongoing clinical trial risks, and lack of product revenue, while sector momentum lifts biotech stocks.
Everpure Stock: $10 Million Insider Sale Lands Before Q1 Earnings
Previous Story

Everpure Stock: $10 Million Insider Sale Lands Before Q1 Earnings

Uber Stock Watch: Robotaxi Bet Hits U.S. Safety Test After Avride Crashes
Next Story

Uber Stock Watch: Robotaxi Bet Hits U.S. Safety Test After Avride Crashes

Go toTop